Comparison of efficacy and safety of insulin detemir and insulin semilente MC [insulin zinc suspension amorphous] in children, adolescents and young adults with type 1 diabetes on basal-bolus regimen.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Insulin detemir; Insulin zinc suspension amorphous
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 07 Jul 2009 Actual patient number (71) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Nov 2005) added as reported by ClinicalTrials.gov.